Prof. Jeremy Goldhaber-Fiebert
Professor of Health Policy at Stanford University
Jeremy Goldhaber-Fiebert, PhD, is a Professor of Health Policy at Stanford University where he is a member of the Department of Health Policy in the School of Medicine and a Core Faculty Member of the Center for Health Policy in the Freeman Spogli Institute.
His research focuses on complex policy decisions surrounding the prevention and management of increasingly common, chronic diseases and the life course impact of exposure to their risk factors. In the context of both developing and developed countries including the US, India, China, and South Africa, he has examined chronic infectious and non-infectious conditions including type 2 diabetes and cardiovascular diseases, human papillomavirus and cervical cancer, tuberculosis, COVID-19, and hepatitis C and on risk factors including smoking, physical activity, obesity, alcohol use, drug use, malnutrition, and other diseases themselves. He combines simulation modeling methods and cost-effectiveness analyses with econometric approaches and behavioral economic studies to address these issues.
Dr. Goldhaber-Fiebert graduated magna cum laude from Harvard College in 1997, with an A.B. in the History and Literature of America. After working as a software engineer and consultant, he conducted a year-long public health research program in Costa Rica with his wife in 2001. Winner of the Lee B. Lusted Prize for Outstanding Student Research from the Society for Medical Decision Making in 2006 and in 2008, he completed his PhD in Health Policy concentrating in Decision Science at Harvard University in 2008. He was elected as a Trustee of the Society for Medical Decision Making in 2011 and Secretary/Treasurer in 2021. In 2023, he was confirmed by the Board of Governors as a member of the Patient-Centered Outcomes Research Institute Methodology Committee.
Dr. Goldhaber-Fiebert will be presenting a course, 'Introduction to Building and Calibrating Simulation Models in R’, on the 3rd of December as a complement to the conference.
Assoc Prof. Dr. Lee-Ling Lim
Senior Consultant Endocrinologist and Head of the Diabetes Care Unit, University of Malaya Medical Centre
Dr. Lim is a Senior Consultant Endocrinologist and Head of the Diabetes Care Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia. As a clinician-scientist, Dr. Lim’s major areas of interest are cardiometabolic medicine with translational and implementation science components.
She sits on the Scientific Work Groups of the American DiabetesAssociation/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative, the WHO Global Diabetes Compact and The Lancet Commission on Diabetes, who provide authoritative resources in tackling the global diabetes epidemic. She has published ~80 peer-reviewed articles including high-impact journals such as The Lancet, Nature, Diabetes Care, and PLoS Medicine.
Dr. Lim has received several awards including the World’s Top 2% Scientists 2022 by Stanford University and the EFSD Albert Renold Fellowship. She is the Editorial Board Members of BMC Medicine and Diabetes/Metabolism Research & Reviews. She is also the Vice President of the Malaysian Osteoporosis Society and Honorary Asst Secretary of the Malaysian Endocrine and Metabolic Society (MEMS).